Both BTK and the related TEC kinases ETK and BMX are abundantly expressed in prostate cancer cells, and knockdown of BTK expression in prostate cancer cells results in reduced proliferative activity (Guo et al., 2014; Kokabee et al., 2015; Chen et al., 2018). The gene discussed is BMX; the disease is prostate cancer.